US equities
|
TSLA
$394.12
▲+5.88%
MU
$910.41
▲+3.74%
SPCX
$148.28
▲+0.54%
NVDA
$216.43
▲+2.59%
META
$632.61
▼-1.56%
AAPL
$342.96
▼-1.37%
SNDK
$1,265.96
▲+2.26%
INTC
$91.61
▲+5.35%
TSLA
$394.12
▲+5.88%
MU
$910.41
▲+3.74%
SPCX
$148.28
▲+0.54%
NVDA
$216.43
▲+2.59%
META
$632.61
▼-1.56%
AAPL
$342.96
▼-1.37%
SNDK
$1,265.96
▲+2.26%
INTC
$91.61
▲+5.35%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Biora Therapeutics, Inc. - Common Stock
(NQ:
PROG
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 6, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biora Therapeutics, Inc. - Common Stock
ZIM Integrated Shipping Services Ltd (NYSE:ZIM) And Progenity, Inc (NYSE: PROG) Emerges As Two Of The Fastest Rising Companies
August 18, 2022
Via
AB Newswire
Topics
Initial Public Offering
PROGENITY INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Progenity, Inc. - PROG
June 11, 2021
From
Kahn Swick & Foti, LLC
Via
Business Wire